Alamar Biosciences Inc.(ALMR:US)
Market Cap$1.682B
Key Metrics
Price$25.28
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$64.59M
Total Assets$186.45M
Net Assets-$178.07M
Total Debt$105.55M
Key Metrics
Price$25.28
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$64.59M
Total Assets$186.45M
Net Assets-$178.07M
Total Debt$105.55M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $26.04M | $13.09M |
Cost of Revenue | $11.58M | $6.7M |
Gross Profit | $14.46M | $6.39M |
| $26.8M | $14.94M | |
| Research and Development | $13.02M | $8.3M |
| Selling, General, and Administrative | $13.79M | $6.64M |
| Other Operating Expenses | - | - |
Operating Income | -$12.35M | -$8.55M |
| -$8.51M | $894K | |
| Non-Operating Interest Income | $539K | $786K |
| Non-Operating Interest Expense | $223K | $46K |
| Other Income/Expense | -$8.83M | $154K |
Income Before Tax | -$20.86M | -$7.66M |
Income Tax | $464K | $0 |
Net Income | -$21.33M | -$7.66M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$21.33M | -$7.66M |
Shares Outstanding (Basic) | 64.89M | 66.52M |
Shares Outstanding (Diluted) | 64.89M | 66.52M |
EPS (Basic) | -$0.32 | -$0.12 |
EPS (Diluted) | -$0.32 | -$0.12 |
EBIT | -$20.64M | -$7.61M |
EBITDA | -$19.47M | -$6.73M |